loadpatents
name:-0.014034032821655
name:-0.013110160827637
name:-0.0051670074462891
Skidmore; Lillian Patent Filings

Skidmore; Lillian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Skidmore; Lillian.The latest application filed is for "compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives".

Company Profile
5.11.13
  • Skidmore; Lillian - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
Grant 11,420,999 - Miao , et al. August 23, 2
2022-08-23
Compositions Containing, Methods Involving, And Uses Of Non-natural Amino Acid Linked Dolastatin Derivatives
App 20210277056 - MIAO; Zhenwei ;   et al.
2021-09-09
Modified Fgf-21 Polypeptides And Their Uses
App 20210261637 - CUJEC; Thomas P. ;   et al.
2021-08-26
Pegylated Porcine Interferon And Methods Of Use Thereof
App 20210177980 - CANNING; Peter Connor ;   et al.
2021-06-17
Modified FGF-21 polypeptides and their uses
Grant 10,961,291 - Cujec , et al. March 30, 2
2021-03-30
Pegylated porcine interferon and methods of use thereof
Grant 10,960,080 - Canning , et al. March 30, 2
2021-03-30
Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
Grant 10,954,270 - Miao , et al. March 23, 2
2021-03-23
Modified Fgf-21 Polypeptides And Their Uses
App 20200031894 - CUJEC; Thomas P. ;   et al.
2020-01-30
Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses
Grant 10,377,805 - Cujec , et al. A
2019-08-13
Pegylated Porcine Interferon And Methods Of Use Thereof
App 20190192673 - CANNING; Peter Connor ;   et al.
2019-06-27
Modified Fgf-21 Polypeptides And Their Uses
App 20180298073 - CUJEC; Thomas P. ;   et al.
2018-10-18
Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids
Grant 9,975,936 - Cujec , et al. May 22, 2
2018-05-22
Compositions Containing, Methods Involving, And Uses Of Non-natural Amino Acid Linked Dolastatin Derivatives
App 20180009845 - Maio; Zhenwei ;   et al.
2018-01-11
Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
Grant 9,796,754 - Miao , et al. October 24, 2
2017-10-24
Modified FGF-21 Polypeptides and Their Uses
App 20170096463 - CUJEC; Thomas P. ;   et al.
2017-04-06
Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids
Grant 9,517,273 - Cujec , et al. December 13, 2
2016-12-13
Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin Derivatives
App 20160052966 - Miao; Zhenwei ;   et al.
2016-02-25
Modified Insulin Polypeptides and Their Uses
App 20150299288 - MIAO; Zhenwei ;   et al.
2015-10-22
Therapeutic Uses Of Modified Fgf-21 Polypeptides Comprising Non-naturally Occurring Amino Acids
App 20150273075 - CUJEC; Thomas P. ;   et al.
2015-10-01
Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin Derivatives
App 20150080559 - Miao; Zhenwei ;   et al.
2015-03-19
Modified insulin polypeptides and their uses
Grant 8,946,148 - Miao , et al. February 3, 2
2015-02-03
Modified Insulin Polypeptides and Their Uses
App 20100298212 - Miao; Zhenwei ;   et al.
2010-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed